ViaDerma, Inc. Provides an Update of Current and Future Product Sales
02 avr. 2018 08h20 HE
|
ViaDerma, Inc.
LOS ANGELES, April 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide a update on current sales of the Company’s flagship product, Vitastem. ViaDerma...
ViaDerma, Inc. Refutes the Recent Announcement by Kasten, Inc.
02 mars 2018 09h15 HE
|
ViaDerma, Inc.
LOS ANGELES, March 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), announced today that it is refuting the announcement by Kasten, Inc. claiming he US District Federal Court ruled...
ViaDerma, Inc., to Initiate Upcoming Field Trial of Comparison for Onychomycosis
02 mars 2015 09h17 HE
|
ViaDerma Licensing
LOS ANGELES, March 2, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM) (The Company), a specialty pharmaceutical company devoted to bringing new products to market, is excited to start...